Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 70, pseudogene (RN7SL70P) is annotated as a pseudogene related to 7SL RNA, a key structural component of the signal recognition particle (SRP) complex, which is essential for the co-translational targeting of secretory and membrane proteins. As a pseudogene, RN7SL70P is generally considered transcriptionally inactive and does not encode a functional RNA or protein product. While the functional 7SL RNA (coded by RN7SL1) plays a well-established role in protein secretion and trafficking, RN7SL70P itself is not known to have biological function, therapeutic relevance, or involvement in disease. There are no drugs or biomarkers associated with this pseudogene, and no safety concerns; its significance is limited to genomic studies on pseudogene evolution and transcription[6][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 70, pseudogene (RN7SL70P).